Insights

Corporate Transparency Act Update: FinCEN Suspends Enforcement

By Charles Alovisetti, Bridgette Nikisher
Mar 5, 2025

The Treasury Department recently suspended enforcement of the Corporate Transparency Act’s Beneficial Ownership Information reporting requirements meaning that businesses failing to submit or update their BOI reports by the March 21 deadline will not face fines, penalties, or enforcement actions. In this Insights post, we discuss the latest developments surrounding CTA enforcement, the Treasury’s plans to limit its scope, anticipated regulatory changes from FinCEN, and ongoing legislative and legal challenges that could reshape compliance obligations.

Read More

South Carolina Medical Cannabis and Hemp-Derived Cannabinoid Legislative Update

By David M. Ullian
Mar 5, 2025

Cannabis-related legislation is once again on the move in South Carolina with the filing of a bill that would establish a regulated medical cannabis program and several bills that would officially regulate consumable products containing hemp-derived cannabinoids, including the increasingly popular beverages containing hemp-derived Delta-9 THC.

Read More

Understanding ESG Requirements for Licensing Colorado Natural Medicine Businesses

By Juliana Todeschi, Joshua Kappel
Mar 4, 2025

Colorado’s Natural Medicine Division has finalized its Environmental, Social, and Governance (ESG) requirements for Natural Medicine Business licensing. These guidelines help applicants create plans that promote sustainability, social impact, and ethical governance. Notably, the rules emphasize honoring Indigenous communities and ensuring transparency in business operations.

Read More

Raising Capital for Your Business: Why Companies Should Avoid Non-Accredited Investors

By Charles Alovisetti
Feb 11, 2025

Startups and growing businesses need capital, but should they accept funds from anyone willing to invest? The answer: probably not. In fact, choosing the right investors—particularly accredited investors—can save you time, money, and future headaches. In this Insights post, we discuss what to look for when selecting an investor and the risks of raising funds from unaccredited investors, including disclosure agreements, preemptive rights issues and IPO complications. Plus, considerations when deciding to work with investors outside of the United States.

Read More

WELCOME TO VICENTE INSIGHTS!

Commentary and analysis on cannabis, hemp, psychedelics, and other emerging therapies from the attorneys and policy specialists at the nation’s leading cannabis law firm.

Subscribe to RSS

POPULAR TOPICS